Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by CIBC Asset Management Inc

CIBC Asset Management Inc lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 1.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,313 shares of the biotechnology company’s stock after selling 162 shares during the quarter. CIBC Asset Management Inc’s holdings in Axon Enterprise were worth $2,406,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of AXON. BKM Wealth Management LLC acquired a new stake in Axon Enterprise during the 4th quarter valued at approximately $32,000. Key Financial Inc grew its position in shares of Axon Enterprise by 367.6% in the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after acquiring an additional 125 shares in the last quarter. Lindbrook Capital LLC grew its position in shares of Axon Enterprise by 43.3% in the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after acquiring an additional 52 shares in the last quarter. Rakuten Securities Inc. acquired a new position in shares of Axon Enterprise in the 4th quarter worth approximately $48,000. Finally, Principal Securities Inc. acquired a new position in shares of Axon Enterprise in the 4th quarter worth approximately $49,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AXON. The Goldman Sachs Group lifted their target price on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. Argus started coverage on Axon Enterprise in a research note on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price objective on the stock. Morgan Stanley boosted their price objective on Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, April 26th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Finally, Craig Hallum lifted their target price on Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $335.27.

Get Our Latest Report on AXON

Insiders Place Their Bets

In other Axon Enterprise news, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $281.72, for a total value of $279,747.96. Following the transaction, the director now directly owns 4,553 shares of the company’s stock, valued at approximately $1,282,671.16. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Axon Enterprise news, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $281.72, for a total value of $279,747.96. Following the transaction, the director now directly owns 4,553 shares of the company’s stock, valued at approximately $1,282,671.16. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Jeri Williams sold 308 shares of the company’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares in the company, valued at $498,282.49. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock valued at $27,684,677 in the last three months. Insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $280.50 on Friday. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $21.17 billion, a price-to-earnings ratio of 82.02 and a beta of 0.91. The stock’s fifty day simple moving average is $300.37 and its 200-day simple moving average is $277.87.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The business had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. Axon Enterprise’s revenue for the quarter was up 34.3% compared to the same quarter last year. On average, sell-side analysts predict that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.